…on the latest industry updates. As we approach another autumn/winter season in the northern hemisphere, Covid-19 vaccines are once again making the headlines, but in the last week we have…
…Reece Armstrong, Editor at DDW. Panelists will discuss the following questions: How has the Covid-19 pandemic influenced the advancement of RNA research? What does the investment landscape look like for…
…generation Covid-19 vaccines clinical trial ICON and the US Biomedical Advanced Research and Development Authority (BARDA) will execute a clinical trial to evaluate the effectiveness of next-generation Covid-19 vaccine candidates….
…Department of Health and Human Services, will execute a clinical trial to evaluate the effectiveness of next-generation Covid-19 vaccine candidates. Next generation Covid-19 vaccines could have the potential to expand…
…the Infection Innovation Consortium (iiCON) at the University of Liverpool, and Reece Armstrong, Editor at DDW. Panelists will discuss the following questions: How has the Covid-19 pandemic influenced the advancement…
…severe neuro-cognitive consequences of Covid-19 (post-Covid or Long Covid), published this study in collaboration with Professor Marion Leboyer from the FondaMental Foundation and Dr Ryad Tamouza, Head Immunologist for the…
…to the Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine. Additional pre-clinical data demonstrate that serum antibodies induced by the updated Covid-19 vaccine, when compared to the Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine, also…
…a mitochondrial activator for long Covid, and the world’s first AI-designed bispecific T cell engager – reflecting the breadth of innovative approaches to disease being employed by researchers across the…
…and neck cancer, an estrogen receptor degrader for breast cancer, a mitochondrial activator for long Covid, and the world’s first AI-designed bispecific T cell engager – reflecting the breadth of…
The US Patent and Trademark Office (USPTO) has granted a patent for Axcella Therapeutics’ long Covid treatment candidate AXA1125. AXA1125 is a novel composition of endogenous metabolic modulators (EMMs) designed…
…Ipsos, said: “Though the pandemic recedes further away in the rear-view mirror, the legacy of the sector’s actions to fight Covid-19 continues to shape its reputation today. The public tend…
